US patent

""

US-patent for Swedish bacterial vaginosis therapy

26 April 2023

The United States Patent and Trademark Office (USPTO) has granted Gedea Biotech’s patent application 16/753,899 directed to gluconic acid derivatives for preventing and/or treating bacterial infections. The patent can be kept in force until 2038. The specific derivative Glucone-delta lactone (GDL) in pHyph is a well-documented substance with a low risk of developing antimicrobial resistance. […]

CT scans of the brain

Potential Alzheimer’s drug receives US patent

12 September 2022

The United States Patent Office (USPTO) has issued a patent covering drug candidate ACD856, which is currently being developed to treat Alzheimer’s disease and other disorders with cognitive impairment. ACD856 is part of AlzeCure Pharma’s NeuroRestore platform, which it is hoped could provide treatments for Alzheimer’s, Parkinson’s disease and depression. These drugs stimulate several important […]